These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 18926552)

  • 1. Noroviral P particle: structure, function and applications in virus-host interaction.
    Tan M; Fang P; Chachiyo T; Xia M; Huang P; Fang Z; Jiang W; Jiang X
    Virology; 2008 Dec; 382(1):115-23. PubMed ID: 18926552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors.
    Tan M; Jiang X
    J Virol; 2005 Nov; 79(22):14017-30. PubMed ID: 16254337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic and Cryo-Electron Microscopy Structure Analysis of a Chimeric Sapovirus Capsid.
    Miyazaki N; Taylor DW; Hansman GS; Murata K
    J Virol; 2015 Dec; 90(5):2664-75. PubMed ID: 26699644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors.
    Tan M; Hegde RS; Jiang X
    J Virol; 2004 Jun; 78(12):6233-42. PubMed ID: 15163716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-terminal arginine cluster is essential for receptor binding of norovirus capsid protein.
    Tan M; Meller J; Jiang X
    J Virol; 2006 Aug; 80(15):7322-31. PubMed ID: 16840313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope mapping of histo blood group antigens bound to norovirus VLPs using STD NMR experiments reveals fine details of molecular recognition.
    Fiege B; Leuthold M; Parra F; Dalton KP; Meloncelli PJ; Lowary TL; Peters T
    Glycoconj J; 2017 Oct; 34(5):679-689. PubMed ID: 28823097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and characterization of virus-like particles and the P domain protein of GII.4 norovirus.
    Koho T; Huhti L; Blazevic V; Nurminen K; Butcher SJ; Laurinmäki P; Kalkkinen N; Rönnholm G; Vesikari T; Hytönen VP; Kulomaa MS
    J Virol Methods; 2012 Jan; 179(1):1-7. PubMed ID: 21600929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human noroviruses' fondness for histo-blood group antigens.
    Singh BK; Leuthold MM; Hansman GS
    J Virol; 2015 Feb; 89(4):2024-40. PubMed ID: 25428879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particles.
    Tan M; Fang PA; Xia M; Chachiyo T; Jiang W; Jiang X
    Virology; 2011 Feb; 410(2):345-52. PubMed ID: 21185050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanobodies targeting norovirus capsid reveal functional epitopes and potential mechanisms of neutralization.
    Koromyslova AD; Hansman GS
    PLoS Pathog; 2017 Nov; 13(11):e1006636. PubMed ID: 29095961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of a rabbit hemorrhagic disease virus binding to histo-blood group antigens.
    Leuthold MM; Dalton KP; Hansman GS
    J Virol; 2015 Feb; 89(4):2378-87. PubMed ID: 25505081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atomic Structure of the Murine Norovirus Protruding Domain and Soluble CD300lf Receptor Complex.
    Kilic T; Koromyslova A; Malak V; Hansman GS
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinities of human histo-blood group antigens for norovirus capsid protein complexes.
    Han L; Kitova EN; Tan M; Jiang X; Pluvinage B; Boraston AB; Klassen JS
    Glycobiology; 2015 Feb; 25(2):170-80. PubMed ID: 25395406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanobody binding to a conserved epitope promotes norovirus particle disassembly.
    Koromyslova AD; Hansman GS
    J Virol; 2015 Mar; 89(5):2718-30. PubMed ID: 25520510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E. coli-expressed recombinant norovirus capsid proteins maintain authentic antigenicity and receptor binding capability.
    Tan M; Zhong W; Song D; Thornton S; Jiang X
    J Med Virol; 2004 Dec; 74(4):641-9. PubMed ID: 15484274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus.
    Tan M; Jiang X
    Nanomedicine (Lond); 2012 Jun; 7(6):889-97. PubMed ID: 22734641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noroviral p-particles as an in vitro model to assess the interactions of noroviruses with probiotics.
    Rubio-del-Campo A; Coll-Marqués JM; Yebra MJ; Buesa J; Pérez-Martínez G; Monedero V; Rodríguez-Díaz J
    PLoS One; 2014; 9(2):e89586. PubMed ID: 24586892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norovirus drug candidates that inhibit viral capsid attachment to human histo-blood group antigens.
    Ali ES; Rajapaksha H; Carr JM; Petrovsky N
    Antiviral Res; 2016 Sep; 133():14-22. PubMed ID: 27421712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for the recognition of blood group trisaccharides by norovirus.
    Cao S; Lou Z; Tan M; Chen Y; Liu Y; Zhang Z; Zhang XC; Jiang X; Li X; Rao Z
    J Virol; 2007 Jun; 81(11):5949-57. PubMed ID: 17392366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of norovirus particles with citrate.
    Koromyslova AD; White PA; Hansman GS
    Virology; 2015 Nov; 485():199-204. PubMed ID: 26295280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.